SCHEMBL5259019

SCHEMBL5259019

Cc1cc(C)nc(Nc2ccc(O)c(-c3nc4ccccc4s3)c2)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.64
MEN1 O00255 6/20 0.64
KMT2A Q03164 6/20 0.64
RAB9A P51151 5/20 0.64
KDM4E B2RXH2 4/20 0.64
POLB P06746 2/20 0.57
SMN1; SMN2 Q16637 4/20 0.56
NPC1 O15118 3/20 0.56
GAA P10253 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
APP P05067 1/20 0.56
THRB P10828 1/20 0.56
ALOX15 P16050 1/20 0.56
CASP1 P29466 1/20 0.56
SNCA P37840 1/20 0.56
CASP7 P55210 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
LMNA P02545 2/20 0.54
TP53 P04637 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5259792 0.92 MAPT (0.58) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL15958900 0.91 MAPT (0.64) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL2590596 0.86 MAPT (0.61) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL12157498 0.86 MAPT (0.61) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL12157483 0.85 MAPT (0.58) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL13857585 0.82 MAPT (0.73) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL5260103 0.81 EGFR (0.62) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL5263632 0.81 APP (0.63) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL12157496 0.80 MAPT (0.54) MAPTMEN1KMT2ARAB9AKDM4E
SCHEMBL13855422 0.79 MAPT (0.68) MAPTMEN1KMT2ARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007009524-A1 2-ARYLBENZOTHIAZOLES AND USES THEREOF 4SC AG (DE) 2007-01-25 WO disclosed
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof 4SC AG (DE) 2007-01-25 US disclosed
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof 4SC AG (DE) 2007-01-25 US disclosed
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof 4SC AG (DE) 2007-01-25 US disclosed
EP-1746096-A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer 4SC AG (DE) 2007-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof NR2E1, NR2E3, NR0B2 MAPT 4822/4885MEN1 4001/4885KMT2A 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.